A phase 1 enzyme replacement study offers promise for severe hypophospahatasia.
Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, 950 West 28th Avenue, Vancouver, BC V5Z4H4, Canada. alicehaw@exchange.ubc.ca
A K
AK
Hawkins